{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:49Z","timestamp":1793836489482,"version":"4.6.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Liver test abnormalities in children with inflammatory bowel disease (IBD) are usually insidious in onset. By the time that symptoms referable to liver disease have appeared, the liver injury may be well advanced. It is, therefore, important that children with an incidental finding of abnormal liver tests are investigated in an appropriate and timely manner.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The most prevalent cause of liver test elevations in paediatric IBD is immune-related liver disease, including primary sclerosing cholangitis, autoimmune sclerosing cholangitis, and autoimmune hepatitis. Although less common, drugs used in the treatment of IBD can also cause liver injury. The diagnosis of drug-induced liver injury relies largely on excluding other causes of liver injury, such as viral hepatitis, nonalcoholic fatty liver disease, and biliary and vascular complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>This review highlights an avenue to a step-wise approach for investigating children with IBD and silent liver test elevations. Central to the timing of diagnostic actions is grading the severity of liver test elevations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001045","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:01:18Z","timestamp":1626307278000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Managing abnormal liver tests in children with inflammatory bowel disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Patrick F.","family":"van Rheenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cld.2018.06.009","article-title":"Acute liver failure: an update","volume":"22","author":"Squires","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Rahim","year":"2019","journal-title":"Liver Transpl"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/ajg.2017.98","article-title":"The natural history of severe acute liver injury","volume":"112","author":"Koch","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"j2083","DOI":"10.1136\/bmj.j2083","article-title":"Diagnosis and management of inflammatory bowel disease in children","volume":"357","author":"Oliveira","year":"2017","journal-title":"BMJ"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.14.331","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease","volume":"14","author":"Saich","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s41395-018-0248-8","article-title":"An assessment of upper limits of normal for ALT and the impact on evaluating natural course of chronic hepatitis B virus infection in Chinese children","volume":"113","author":"Pan","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"Guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/hep.29542","article-title":"New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase): effects of age, sex, body mass index, and pubertal stage","volume":"68","author":"Bussler","year":"2018","journal-title":"Hepatology"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12519-018-0126-x","article-title":"Establishment of age- and gender-specific pediatric reference intervals for liver function tests in healthy Han children","volume":"14","author":"Li","year":"2018","journal-title":"World J Pediatr"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2019.01.001","article-title":"Pediatric reference intervals of liver and renal function tests from birth to adolescence in Chinese children as performed on the Olympus AU5400","volume":"490","author":"Liu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2019.09.006","article-title":"Data mining of reference intervals for coagulation screening tests in adult patients","volume":"499","author":"Zierk","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/MCG.0000000000001084","article-title":"Hepatotoxicity of inflammatory bowel disease medications","volume":"52","author":"Shamberg","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3389\/fphar.2019.00853","article-title":"Roussel Uclaf Causality Assessment Method for drug-induced liver injury: present and future","volume":"10","author":"Danan","year":"2019","journal-title":"Front Pharmacol"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOG.0000000000000636","article-title":"Signatures in drug-induced liver injury","volume":"36","author":"Tillmann","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"2173.e8","DOI":"10.1016\/j.cgh.2015.06.017","article-title":"The art and science of diagnosing and managing drug-induced liver injury in 2015 and beyond","volume":"13","author":"Lewis","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"m122","DOI":"10.1136\/bmj.m122","article-title":"SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist","volume":"368","author":"Porcino","year":"2020","journal-title":"BMJ"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and nonorgan specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"144.e3","DOI":"10.1016\/j.jpeds.2019.07.065","article-title":"Inflammatory bowel disease in children with elevated serum gamma glutamyltransferase levels","volume":"215","author":"Chandrakumar","year":"2019","journal-title":"J Pediatr"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"109101","DOI":"10.1016\/j.ejrad.2020.109101","article-title":"Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC)","volume":"129","author":"Ringe","year":"2020","journal-title":"Eur J Radiol"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies","volume":"25","author":"Fung","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2010.483","article-title":"Who wants to take a thiopurine holiday?","volume":"106","author":"Higgins","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The medical management of paediatric Crohn's disease: an ECCO-ESPGHAN guideline update","volume":"15","author":"van Rheenen","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11894-020-00781-3","article-title":"Hepatotoxicty of agents used in the management of inflammatory bowel disease: a 2020 update","volume":"22","author":"Barnhill","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ncp.10474","article-title":"ASPEN consensus recommendations for refeeding syndrome","volume":"35","author":"da Silva","year":"2020","journal-title":"Nutr Clin Pract"},{"key":"R36-20250730","article-title":"Liver disease in obesity and underweight: the two sides of the coin. A narrative review","author":"Risi","year":"2020","journal-title":"Eat Weight Disord"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2018.12.003","article-title":"Hepatic complications of inflammatory bowel disease","volume":"23","author":"Mahfouz","year":"2019","journal-title":"Clin Liver Dis"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00383-017-4083-6","article-title":"Pediatric choledochal cysts: diagnosis and current management","volume":"33","author":"Soares","year":"2017","journal-title":"Pediatr Surg Int"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ibd\/izaa053","article-title":"The natural history, treatments, and outcomes of portal vein thrombosis in patients with inflammatory bowel disease","volume":"27","author":"Naymagon","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/flgastro-2018-101037","article-title":"Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease","volume":"10","author":"Yaccob","year":"2019","journal-title":"Frontline Gastroenterol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:02:54Z","timestamp":1753898574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001045","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]}}}